Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,895
Closed -$311K 1199
2017
Q3
$311K Buy
6,895
+547
+9% +$24.2K 0.01% 879
2017
Q2
$269K Sell
6,348
-1,069
-14% -$41.5K 0.01% 897
2017
Q1
$273K Buy
7,417
+111
+2% +$4.17K 0.01% 938
2016
Q4
$265K Buy
+7,306
New +$259K ﹤0.01% 918
2016
Q3
Sell
-18,856
Closed -$526K 1057
2016
Q2
$526K Buy
+18,856
New +$533K 0.01% 580
2015
Q1
Sell
-11,606
Closed -$472K 1225
2014
Q4
$472K Buy
+11,606
New +$495K 0.01% 934
2014
Q3
Sell
-11,606
Closed -$508K 1456
2014
Q2
$508K Hold
11,606
0.01% 926
2014
Q1
$508K Sell
11,606
-34,236
-75% -$1.55M 0.01% 882
2013
Q4
$2.18M Buy
+45,842
New +$2.17M 0.03% 455

Other funds holding HSBC

Integral Derivatives's HSBC Position: Q2 2017 in Review

Integral Derivatives sold out of HSBC (HSBC) in Q2 2017, closing a stake of 10,045 shares — an estimated $390K sold.

Integral Derivatives first reported a position in HSBC in Q3 2014 and held it in 4 quarters. The position peaked at $1.59M in Q2 2015. 364 funds tracked by Wall St. Rank hold HSBC as of Q2 2017.

  • Integral Derivatives reported no remaining HSBC position as of Q2 2017 after selling out during the quarter.
  • Integral Derivatives sold 10,045 HSBC shares in Q2 2017, an estimated $390K.
  • Integral Derivatives first reported a position in HSBC in Q3 2014 and held it in 4 quarters.
  • Integral Derivatives's HSBC position peaked at $1.59M in Q2 2015.
  • 364 funds tracked by Wall St. Rank held HSBC as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.